Anzeige
Meldung des Tages: NASDAQ, Washington, Psychedelika – und Optimi steht im Zentrum der Explosion

Rogers News

Aktie
WKN:  863178 ISIN:  US7751331015 US-Symbol:  ROG Branche:  Computer-Ausrüstung, Geräte u. Bauteile Land:  USA
104,00 €
+0,00 €
0,00%
08:37:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
1,49 Mrd. €
Streubesitz
-
KGV
72,58
Index-Zuordnung
-

Rogers News

18.03.26 - PR Newswire
Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation
Roche expands mass spectrometry menu to include steroid assays receiving CLIA 'moderate complexity' designation PR Newswire
16.03.26 - PR Newswire
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease PR ...
16.03.26 - PR Newswire
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease PR ...
05.03.26 - PR Newswire
New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
New survey demonstrates how diabetes limits day-​to-day freedom for people around the world and highlights need for predictive tools PR Newswire
16.12.25 - PR Newswire
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
Roche announces U.S. launch of next-​generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities PR Newswire
12.11.25 - PR Newswire
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche PR Newswire
12.11.25 - PR Newswire
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche PR Newswire
13.10.25 - PR Newswire
Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
Roche's Elecsys® pTau181 becomes the only FDA-​cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology PR Newswire
18.09.25 - PR Newswire
Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test PR Newswire
16.09.25 - PR Newswire
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience PR ...
16.09.25 - PR Newswire
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience PR ...
05.09.25 - PR Newswire
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients PR Newswire
05.09.25 - PR Newswire
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients PR Newswire
24.07.25 - PR Newswire
Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
Roche Diagnostics showcases science-​driven leadership and innovation at ADLM 2025 PR Newswire
12.05.25 - PR Newswire
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr 0,00%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »